AbsoluteRiskLCISDoxorubicinLumpectomyAdjuvantTherapyTumorGradeCMFChemotherapyMultimodalityTherapyAdvocacyMultifocalTumorsACChemotherapyCAMMorpheaIn-situCarcinomaDocetaxelHormoneReceptorStatusWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.LumpCyclophosphamideRaloxifeneMastectomyRADECOGScoreKappaEpsilonApoptosisBrachytherapyBilateralProphylacticMastectomyStagingPARPInhibitorsBreastCancerGeneticCounselingPagetDiseaseBI-RADSBevacizumabER+/-ChemopreventionDimplingBRCAGenePalpationCytostatic1 in 8womenDown-StagingBreastTomosynthesisLymphNodeStatusCapecitabineMRIMegestrolAcetateImmunotherapySelf-examinationGermlineMutationCDK4/6InhibitorsHER-2AdenocarcinomaBOCALapatinibCytotoxicPhyllodesTumorEGFRmTORInhibitorsAntiemetics5-FluorouracilHormoneReplacementTherapyFISHChemotherapyAromataseInhibitorsLymphoscintigraphyFlowCytometryTamoxifenAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPhysicalactivity mayreduce therisk of breastcancersCalcificationsGeneticPredispositionProgestinGuaranteedRenewableInsurancePathologicResponseCheckpointInhibitorOligometastasesHerceptinMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AntibodyTherapyFamilyHistoryWomen ages40+ shouldhave a clinicalbreast examat least yearlyOvarianSuppressionAngiogenesisRadiotherapyRelapseMastodyniaBiopsyMetastasisAlopeciaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearNeoadjuvantTherapyPaclitaxelDefinitiveSurgeryBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GeneMutationCystCo-survivorPI3KinaseInhibitorsCachexiaKi-67RateAnastrozoleTriple +/-BreastCancerTyrosine-KinaseInhibitorGailModelPrecisionMedicineAyurvedaEstrogen/EstradiolAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoseDenseTherapyPalbociclibIntraductalPapillomaMethotrexateFibroadenomaSERMAbsoluteRiskLCISDoxorubicinLumpectomyAdjuvantTherapyTumorGradeCMFChemotherapyMultimodalityTherapyAdvocacyMultifocalTumorsACChemotherapyCAMMorpheaIn-situCarcinomaDocetaxelHormoneReceptorStatusWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.LumpCyclophosphamideRaloxifeneMastectomyRADECOGScoreKappaEpsilonApoptosisBrachytherapyBilateralProphylacticMastectomyStagingPARPInhibitorsBreastCancerGeneticCounselingPagetDiseaseBI-RADSBevacizumabER+/-ChemopreventionDimplingBRCAGenePalpationCytostatic1 in 8womenDown-StagingBreastTomosynthesisLymphNodeStatusCapecitabineMRIMegestrolAcetateImmunotherapySelf-examinationGermlineMutationCDK4/6InhibitorsHER-2AdenocarcinomaBOCALapatinibCytotoxicPhyllodesTumorEGFRmTORInhibitorsAntiemetics5-FluorouracilHormoneReplacementTherapyFISHChemotherapyAromataseInhibitorsLymphoscintigraphyFlowCytometryTamoxifenAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPhysicalactivity mayreduce therisk of breastcancersCalcificationsGeneticPredispositionProgestinGuaranteedRenewableInsurancePathologicResponseCheckpointInhibitorOligometastasesHerceptinMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AntibodyTherapyFamilyHistoryWomen ages40+ shouldhave a clinicalbreast examat least yearlyOvarianSuppressionAngiogenesisRadiotherapyRelapseMastodyniaBiopsyMetastasisAlopeciaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearNeoadjuvantTherapyPaclitaxelDefinitiveSurgeryBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GeneMutationCystCo-survivorPI3KinaseInhibitorsCachexiaKi-67RateAnastrozoleTriple +/-BreastCancerTyrosine-KinaseInhibitorGailModelPrecisionMedicineAyurvedaEstrogen/EstradiolAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoseDenseTherapyPalbociclibIntraductalPapillomaMethotrexateFibroadenomaSERM

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Absolute Risk
  2. LCIS
  3. Doxorubicin
  4. Lumpectomy
  5. Adjuvant Therapy
  6. Tumor Grade
  7. CMF Chemotherapy
  8. Multimodality Therapy
  9. Advocacy
  10. Multifocal Tumors
  11. AC Chemotherapy
  12. CAM
  13. Morphea
  14. In-situ Carcinoma
  15. Docetaxel
  16. Hormone Receptor Status
  17. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  18. Lump
  19. Cyclophosphamide
  20. Raloxifene
  21. Mastectomy
  22. RAD
  23. ECOG Score
  24. Kappa Epsilon
  25. Apoptosis
  26. Brachytherapy
  27. Bilateral Prophylactic Mastectomy
  28. Staging
  29. PARP Inhibitors
  30. Breast Cancer
  31. Genetic Counseling
  32. Paget Disease
  33. BI-RADS
  34. Bevacizumab
  35. ER +/-
  36. Chemoprevention
  37. Dimpling
  38. BRCA Gene
  39. Palpation
  40. Cytostatic
  41. 1 in 8 women
  42. Down-Staging
  43. Breast Tomosynthesis
  44. Lymph Node Status
  45. Capecitabine
  46. MRI
  47. Megestrol Acetate
  48. Immunotherapy
  49. Self-examination
  50. Germline Mutation
  51. CDK4/6 Inhibitors
  52. HER-2
  53. Adenocarcinoma
  54. BOCA
  55. Lapatinib
  56. Cytotoxic
  57. Phyllodes Tumor
  58. EGFR
  59. mTOR Inhibitors
  60. Antiemetics
  61. 5-Fluorouracil
  62. Hormone Replacement Therapy
  63. FISH
  64. Chemotherapy
  65. Aromatase Inhibitors
  66. Lymphoscintigraphy
  67. Flow Cytometry
  68. Tamoxifen
  69. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  70. Physical activity may reduce the risk of breast cancers
  71. Calcifications
  72. Genetic Predisposition
  73. Progestin
  74. Guaranteed Renewable Insurance
  75. Pathologic Response
  76. Checkpoint Inhibitor
  77. Oligometastases
  78. Herceptin
  79. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  80. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  81. Antibody Therapy
  82. Family History
  83. Women ages 40+ should have a clinical breast exam at least yearly
  84. Ovarian Suppression
  85. Angiogenesis
  86. Radiotherapy
  87. Relapse
  88. Mastodynia
  89. Biopsy
  90. Metastasis
  91. Alopecia
  92. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  93. Neoadjuvant Therapy
  94. Paclitaxel
  95. Definitive Surgery
  96. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  97. Gene Mutation
  98. Cyst
  99. Co-survivor
  100. PI3 Kinase Inhibitors
  101. Cachexia
  102. Ki-67 Rate
  103. Anastrozole
  104. Triple +/- Breast Cancer
  105. Tyrosine-Kinase Inhibitor
  106. Gail Model
  107. Precision Medicine
  108. Ayurveda
  109. Estrogen/Estradiol
  110. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  111. Dose Dense Therapy
  112. Palbociclib
  113. Intraductal Papilloma
  114. Methotrexate
  115. Fibroadenoma
  116. SERM